" class="no-js "lang="en-US"> Neurolens - Medtech Alert
Tuesday, September 16, 2025
Neurolens | Pharmtech Focus

Neurolens

About Neurolens

Neurolens

Neurolens commercializes breakthrough technology to improve vision care. With patented Contoured Prism technology, Neurolenses are the first and only prescription lenses that go beyond visual acuity to provide comfort for the majority of adults who complain of headaches, neck/shoulder pain and eyestrain when using digital devices, reading or doing detail work. The Neurolens Contoured Prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. Technology from Neurolens is only available to Independent Eye Care Providers.

Related Story

Neurolens Raises $67 Million from MVM Partners, Falcon Vision/KKR, Marshall Wace & Existing Investors

September 13 2022

Neurolens, a company commercializing innovative solutions to optimize vision, today announced completion of a $67 million financing. […]